Electrocore (ECOR) Receives a Hold from JMP Securities

JMP Securities analyst David Turkaly reiterated a Hold rating on Electrocore (ECORResearch Report) today. The company’s shares closed today at $0.61.

According to TipRanks, Turkaly is a 4-star analyst with an average return of 6.1% and a 52.51% success rate. Turkaly covers the Healthcare sector, focusing on stocks such as Apyx Medical, Haemonetics, and AxoGen.

Electrocore has an analyst consensus of Moderate Buy, with a price target consensus of $1.50.

See today’s best-performing stocks on TipRanks >>

ECOR market cap is currently $46.94M and has a P/E ratio of -2.34.

Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ECOR in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. The company’s therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.

Read More on ECOR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More